Abimbola Adegoke

Dr. Abimbola Adegoke

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Kola AdegokeKola Adegoke
Kola Adegoke
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
AAAkorede Adekoya
Akorede Adekoya
ABAyoola Emmanuel Bayowa
Ayoola Emmanuel Bayowa
MSMallika Singh
Mallika Singh
Background: Interoperability is fundamental for advancing digital health and digital therapeutics, particularly with the integration of technologies such as artificial intelligence (AI), blockchain, and federated learning. Low- and middle-income countries (LMICs), where digital infrastructure remains fragmented, face specific challenges in implementing standardized and scalable systems. Methods: This scoping review was conducted using the Arksey and O’Malley framework, refined by Levac et al., and the Joanna Briggs Institute guidelines. Five databases (PubMed, Scopus, IEEE Xplore, ACM Digital Library, and Google Scholar) were searched for peer-reviewed English language studies published between 2015 and 2025. We identified 255 potentially eligible articles and selected a 10% random sample (n = 26) using Stata 18 by StataCorp LLC, College Station, TX, USA, for in-depth data charting and thematic synthesis. Results: The selected studies spanned over 15 countries and addressed priority technologies, including mobile health (mHealth), the use of Health Level Seven (HL7)’s Fast Healthcare Interoperability Resources (FHIR) for data exchange, and blockchain. Interoperability enablers include standards (e.g., HL7 FHIR), data governance frameworks, and policy interventions. Low- and Middle-Income Countries (LMICs) face common issues related to digital capacity shortages, legacy systems, and governance fragmentation. Five thematic areas were identified: (1) policy and governance; (2) standards-based integration; (3) infrastructure and platforms; (4) emerging technologies; and (5) LMIC implementation issues. Conclusions: Emerging digital health technologies increasingly rely on interoperability standards to scale their operation. Although global standards such as FHIR and the Trusted Exchange Framework and Common Agreement (TEFCA) are gaining momentum, LMICs require dedicated governance, infrastructure, and capacity investments to make equitable use feasible. Future initiatives can benefit from using science- and equity-informed frameworks.

1 July 2025 in Journal of Primary Care & Community Health
Verified
Journal Article
Open access
Kola AdegokeKola Adegoke
Kola Adegoke
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
TKTemitope Kayode
Temitope Kayode
Background: In Canadian healthcare, systemic racism subverts commitment to universal coverage by building inequities into the system of governance, regulation, and clinical practice. Although racial disparities have been documented, little attention has been paid to how institutional structures perpetuate these inequities. Objective: This study critically examines the organizational aspects of racism in the Canadian healthcare system. It aims to identify structural obstacles faced by racialized patients and foreign-trained physicians and to provide policy recommendations grounded in evidence. Methods: The authors employed a narrative review framework for qualitative analysis of documents. Public inquiries (eg, Truth and Reconciliation Commission and Viens Report), government audits (eg, PHAC and CHRC), case files (eg, Brian Sinclair, Joyce Echaquan, and Dr. Akinbiyi), and peer-reviewed publications between 2000 and 2024 were the data sources. Thematic coding occurs across 4 areas: (1) institutional discrimination, (2) licensing and workforce exclusion, (3) patient and cultural safety, and (4) accountability gaps. Results: The review found continuing institutional disregard for Indigenous and Black patients, and the disparities were most marked in emergency and maternal services. Internationally educated doctors face opaque and delayed credentialing procedures, which can exacerbate workforce disparities. Case examples illustrate how system failures, including disregarding patient suffering, ignoring cultural requirements, and inadequate oversight, can lead to harm. It is a recurring pattern in which the recommended action is not taken following a review, suggesting organizational resistance to change. Discussion: Canadian systemic racism in health care occurs through omissions (failure to act on reform) and commissions (institutional exclusion). To tackle this, it is necessary to entrench antiracism in legislation, make cultural safety training a requirement, collect race-disaggregated data, and transform licensing routes. Conclusion: Universal healthcare is not equitable unless systemic racism is eliminated. Systemic changes that recalibrate healthcare governance in accordance with antiracism and equity values are necessary to provide safe and inclusive care.

1 March 2026 in INQUIRY: The Journal of Health Care Organization, Provision, and Financing
Verified
Journal Article
Open access
AAAbimbola Adegoke
Abimbola Adegoke
Kola AdegokeKola Adegoke
Kola Adegoke
ODOlajide Alfred Durojaye
Olajide Alfred Durojaye
Deborah DawoduDeborah Dawodu
Deborah Dawodu
AAAbiodun Isola Aluko
Abiodun Isola Aluko
KKKenneth A. Knapp
Kenneth A. Knapp
The Affordable Care Act (ACA) allowed states to expand Medicaid eligibility, potentially improving access to care and reducing psychological distress among lower-income adults. However, evidence on population-level mental health effects remains mixed, and conventional two-way fixed-effects difference-in-differences (DiD) estimates can be biased under staggered adoption. This study estimates the effect of Medicaid expansion on frequent mental distress (FMD) among non-elderly adults, with emphasis on lower-income adults. We used Behavioral Risk Factor Surveillance System (BRFSS) data from 2011 to 2024 and restricted the sample to adults aged 18 to 64 years. FMD was defined as ≥14 days of poor mental health in the past 30 days. Medicaid expansion was assigned by state implementation year. For transparent weighting and computational feasibility, we collapsed microdata to state-year prevalence using BRFSS survey weights and applied prespecified minimum cell-size and effective-sample screens (lower-income panel: unweighted N ≥ 150 and Kish n_eff ≥ 50; pooled and higher-income panels: n_eff ≥ 200). We estimated group-time average treatment effects using the Callaway–Sant’Anna staggered DiD framework (csdid), clustered standard errors at the state level, and used pair-balanced observations when panels were unbalanced. Income strata were defined using BRFSS household income categories (lower-income: inc_cat = 1; higher-income: inc_cat ∈ {7,8}) and are interpreted as economic-status proxies rather than Medicaid eligibility. In the lower-income state-year panel (353 state-years), Medicaid expansion was not associated with a statistically significant change in FMD (ATT −0.0125; 95% CI −0.0521 to 0.0271; P = .54). Estimates in the higher-income (656 state-years) and pooled (709 state-years) panels were similarly small and not statistically significant. Event-time estimates indicated modest heterogeneity at selected leads/lags without a consistent post-expansion pattern. Medicaid expansion was not associated with significant reductions in population-level frequent mental distress during 2011 to 2024. Any mental health effects appear modest and heterogeneous across cohorts and follow-up periods, suggesting that insurance expansion alone may be insufficient to shift population psychological distress without complementary behavioral health capacity and upstream social supports.

19 May 2026 in Health Services Insights
Verified
Journal Article
Open access
Kola AdegokeKola Adegoke
Kola Adegoke
ODOlajide Alfred Durojaye
Olajide Alfred Durojaye
AAAbimbola Adegoke
Abimbola Adegoke
AAAdeyinka Adegoke
Adeyinka Adegoke
Background: Soaring drug prices pose a significant obstacle to affordable and equitable access to medicines in high-income healthcare systems. This study compares two leading reform tool families, Most Favored Nation (MFN)/international reference pricing (IRP) and value-based contracting (VBC), across the United States, Canada, and the United Kingdom, with attention to cost containment, value-linked incentive design, equity of access, and implementation feasibility. U.S. policy developments (CMS Innovation Center’s GENEROUS, GLOBE, and GUARD models) extend international benchmark-based design options beyond the 2020 MFN rule. Methods: Guided by institutional and governance theories, we conducted a structured comparative policy analysis using a four-dimensional trade-off matrix. Cases from the United States, Canada, and the United Kingdom were selected using a most-different-systems design. Documents from 2007 to 2025 were coded for cost containment, value-linked incentive design, equity, and implementation feasibility. To reduce subjectivity, scores were assigned using prespecified rubric anchors, conservative scoring rules for borderline cases, and a sensitivity check of adjacent-score judgments. Design-stage U.S. benchmark-based model materials assessed on March 5, 2026, were incorporated descriptively and not considered as outcome evidence. Results: The United Kingdom model, centered on the National Institute for Health and Care Excellence (UK NICE) and the Voluntary Scheme for Branded Medicines Pricing, Access and Growth (VPAG), was most consistently aligned across all four dimensions (design-feature alignment). Canada’s Patented Medicine Prices Review Board (PMPRB) supports affordability and baseline access, with implementation variation across provinces and more limited adoption of outcomes-based contracting. U.S. MFN/IRP initiatives and VBC pilots show lower alignment on equity and feasibility in a multi-payer environment characterized by contested authority and variable data/contracting capacity. Emerging CMS Innovation Center proposals (GENEROUS, GLOBE, GUARD) indicate continued federal interest in benchmark-based designs, but empirical impacts remain to be evaluated. Conclusions: MFN/IRP anchoring and VBC are implementation-intensive tools whose performance depends on institutional fit. A hybrid approach, using international benchmarks as inputs for negotiations and expanding value-linked agreements where measurement and governance prerequisites are met, may offer a more feasible U.S. pathway. This study provides a repeatable framework for assessing drug pricing reforms and illustrates how institutional alignment conditions the implementability of tools. Design-feature scores reflect policy design and governance capacity, not realized outcomes.

14 July 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Kola AdegokeKola Adegoke
Kola Adegoke
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
AAAkorede Adekoya
Akorede Adekoya
ABAyoola Emmanuel Bayowa
Ayoola Emmanuel Bayowa
MSMallika Singh
Mallika Singh
Background:Ubiquitous health (uHealth) and digital therapeutics require interoperable digital ecosystems to achieve an effective and scalable implementation. Alignment between technical standards and regulations is crucial to ensure the secure and patient-centric exchange of data as these technologies continue to evolve. Objective: This narrative review examines the existing interoperability frameworks that support uHealth and digital therapeutics. Technical standards and governance models were evaluated to identify barriers and recommend future directions for the universally scalable integration of these frameworks. Method: The authors conducted a systematic narrative synthesis to review existing interoperability standards, such as HL7 FHIR and TEFCA, as well as prominent regulations, including HIPAA and the GDPR. Real-world deployments, including those by the U.S. Department of Veterans Affairs, were examined to derive practical lessons. Emerging technologies, including AI, blockchain, and federated learning, were also considered, along with their potential contributions to interoperability. Results: This review highlights ongoing difficulties, including uneven standard implementation, disjointed regulatory regimes, sparse digital infrastructure, and semantic discrepancies among systems. These problems are particularly prevalent in low-income and middle-income nations. New technologies represent promising, yet untapped, remedies. Conclusion: Achieving sustainable interoperability requires reforming governance, adopting modular and standards-based architectures, and fostering widespread stakeholder engagement. Bridging the divide between policy and technology is crucial for building resilient digital health ecosystems that can support equitable, personalized, and globally integrated care delivery.

23 January 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Kola AdegokeKola Adegoke
Kola Adegoke
ODOlajide Alfred Durojaye
Olajide Alfred Durojaye
AAAbimbola Adegoke
Abimbola Adegoke
Deborah DawoduDeborah Dawodu
Deborah Dawodu
AAAdeyinka Adegoke
Adeyinka Adegoke
EAEunice Bisola Akano
Eunice Bisola Akano
Background: U.S. hospitals have increasingly affiliated with multi-hospital chains, raising questions about whether consolidation yields operational efficiencies or primarily reflects integration costs and market power. Evidence on the dynamic financial response to chain entry—especially in recent years—remains limited.Objective: To estimate dynamic association in hospital financial margins around sustained chain joining using a staggered-adoption-robust event-study design.Methods: We analyzed a RAND-processed HCRIS hospital panel (2014–2023). Dynamic effects were estimated using the Sun & Abraham interaction-weighted event-study estimator with hospital and year fixed effects and hospital-clustered standard errors. We implemented two baseline rules (“has2014” and “entry”) and examined total, operating, and cash-flow margins. To reduce ratio outliers, margins were cleaned using year-specific denominator screening and hard caps for extreme values (|margin|>500%), then winsorized within year (p1/p99) for main analyses. Depending on outcome and baseline rule, models used approximately 13,000–24,000 hospital-year observations, covering ~2,600–2,900 hospitals and roughly 600 sustained chain joins. Robustness checks included a balanced-panel restriction, a treated-only stacked specification, placebo assignment among never-treated hospitals, and ownership-stratified estimates.Results: Lead coefficients were generally small, but cash-flow margins exhibited a statistically detectable negative lead at t = −4 in both baseline rules (p≈0.03), while other leads were typically indistinguishable from zero. Post-entry effects were modest and imprecise across outcomes. Total margins showed near-zero contemporaneous changes at t=0 and small negative estimates in years 1–3 that attenuated by year 4. Operating and cash-flow margins displayed small post-entry declines around t=2 (≈1 percentage point in magnitude; p≈0.06–0.09). Robustness checks (balanced panel, stacked design, placebo) broadly supported a null or weak-transient pattern. Ownership stratification suggested modest longer-run improvements for nonprofit hospitals in later post years (e.g., t=4: +3.7 percentage points; p=0.045), while for-profit estimates were mixed and imprecise.Conclusions: Over 2014–2023, sustained chain joining was not associated with consistent, sustained improvements in hospital financial margins on average. Observed changes were small, often imprecise, and in some outcomes suggest modest short-run declines consistent with integration costs. Continued monitoring with longer post-entry windows and additional outcomes is warranted.